Applying a Consumer Approach to eClinical Technology
May 3rd 2022Tuesday, May 3, 2022 at 11am EDT | 7am PDT | 3pm BST | 4pm CEST What can the eClinical technology industry learn from consumer-focused technology companies? They can learn effective approaches that help engage, incentivize, and motivate patients in clinical trials, to improve recruitment and decrease attrition.
Moving Science Forward in Alzheimer’s Disease Clinical Trials
April 28th 2022Thursday April 28, 2022 at 11 am ET In this webinar, IQVIA experts will share how to harness data, technology, and advanced analytics to inclusively recruit the right patients in the right places at the right time into Alzheimer’s disease clinical trials.
Oncology Drug Development: Identifying Regulator and Payer Evidence Needs
April 12th 2022Tuesday, April 12, 2022 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST ** Tuesday, April 19, 2022 at 8:30am CST | 5:30pm PDT | 8:30PM EDT This webinar will include an educational session with Parexel experts, who will address how to build an evidence strategy for your cancer drug that is both approvable and reimbursable.
BYOD is Here to Stay: Considerations for implementing a BYOD eCOA strategy
March 22nd 2022Tuesday, March 22, 2022 at 11am EST In this webinar, IQVIA eCOA leaders Anthony Mikulaschek, Melissa Mooney and J.C. Wilson will explore how to implement a bring your own device (BYOD) strategy within your study, relevant BYOD regulatory considerations, and where the market is going from here. Specific points within this webinar include how the pandemic has furthered the adoption of BYOD, the benefits of BYOD, including reduced patient burden, reduced costs, and increased patient compliance, and how to develop a BYOD strategy and considerations to be made during planning and implementation.
Enriching Oncology Studies with RWD Before, During and After the Trial
March 17th 2022Thursday, March 17, 2022 at 2pm EDT | 11am PT | 6pm GMT | 7pm CET Oncology trials of the future are enriched with real-world data. Learn how to unlock better patient outcomes, faster research, and lower healthcare costs by combining a SaaS DCT platform with real-world data connectivity.
Elevating the Site-Sponsor Experience: Learning Management SaaS in Clinical Trials
March 9th 2022Wednesday, March 9, 2022 at 11am EDT Are you looking for a digital approach to protocol training? See the cross-trial solution that’s eliminating repetitive trainings and saving precious time during study start-up, all while boosting quality and auditability.
Clinical Data Flow: The Foundation of a Biostatistics Ecosystem within a Data Universe
February 24th 2022Thursday, 24th February 2022, 11:00 EST** Data plays a central role within drug discovery and as decentralized trials become more prevalent in the industry, the need to process and engage with enterprise level solutions and the integration of technology to map data to standards become a must. As a central conduit to this IQVIA Biostatistics will share the importance of how to maximize end to end efficiencies through compliance to standards and together provide an understanding to how data flow is an integral part of transformative biostatistics technologies and processes can accelerate clinical development across an organization through an innovative outsourcing approach.
Elevating the Site-Sponsor Experience: SaaS-Based Safety Notifications for Clinical Trials
February 16th 2022Wednesday, February 16, 2022 at 11am EST Are duplicative and voluminous safety letters from your clinical trials overwhelming investigators and staff? See how the Safety Notifications module of the IQVIA Investigator Site Portal can ease the administrative burden and put the focus back on patient safety in this complimentary webinar from IQVIA Technologies.
Elevating the Site-Sponsor Experience: SaaS-Based Feasibility and Site Selection for Clinical Trials
January 26th 2022Wednesday, January 26, 2022 at 11am EST Are your feasibility assessments repetitious and frustrating for everyone involved? See why sites are already saying they are “highly satisfied” with an all-new Feasibility module from IQVIA Technologies in this complimentary webinar.
Embarking on the biotech journey: how to build a long-term plan for successful drug development
December 8th 2021Wednesday December 8, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET Join this webinar to learn how to approach the early stages of drug development and build a long-term plan to advance your drug to market.
Future of RBM: Aligning monitoring of clinical trials with technological and societal evolution
November 30th 2021Tuesday, November 30th, 2021 at 11am EST Current changes in technology and the impact of the COVID pandemic has greatly accelerated the adoption of RBM methodology and AI/ML assisted risk analysis. How are these changing directly impacting your future clinical trials as the industry is reorienting itself around a new normal with regards to monitoring and insights provided by integrated data reviews.
Best Practices for Optimizing Your Protocol, Country and Site Feasibility Strategy
November 17th 2021Now Available On Demand! In this webinar, we will explore best practices to optimize your protocol, country and site feasibility strategy by employing a robust multi-channel strategy and a risk management feedback loop to monitor and mitigate risks throughout the project.
Making Every Connection Count- IQVIA Connected Devices powers clinical trials with better data
November 2nd 2021Tuesday, November 2, 2021 at 11am EDT Get treatments to patients faster and deliver a better experience for both patients and clinical trial sites. Join IQVIA leaders Jeff Noll and Sara Pawley and learn how IQVIA matches the right connected device for each study protocol to enhance data quality, speed data collection, and accelerate trial outcomes.
New EU (536/2014) Clinical Trial Regulation Set to Attract More Studies and Innovation
October 28th 2021The way clinical trials are conducted in the European Union will undergo a major change when (EU) No 536/2014 comes into effect in January 2022. But just being compliant with the regulation should not be considered enough – forward-looking organizations are rethinking how technology can play an important part in bringing efficiencies to clinical trials, by reducing failures and driving operational changes beyond compliance.
2021 Research: The Impact of New Clinical Trial Approaches Adopted During Pandemic
October 26th 2021***Live: Tuesday, October 26, 2021 at 11 EDT | 8am PDT | 5pm CEST | 4pm BST*** Oracle Health Sciences reveals new research conducted to understand the technology adaptations that were made to clinical trials during the pandemic, the effect of these adaptations, and the impact of these changes on the future of clinical trials.
Empowered Trial Selection with Weighting and Prioritization Tools
September 30th 2021Thursday, September 30, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST Give yourself a competitive edge by learning how the world’s leading designer of innovative clinical trials can help you integrate elements of economic theory to your clinical trial design. Optimize sample size, speed, and power by exploring a broader array of designs and quickly identifying those that meet your objectives.
Making expedited regulatory pathways work for global drug development programs
September 22nd 2021Europe & US: Wednesday, September 22, 2021 at 1:30pm BST | 8:30am EDT Asia & US: Tuesday, September 28, 2021 at 7:30am CST | 4:30pm PDT This panel discussion will include a lively conversation with Parexel regulatory experts from USA, Europe, and China, who will address how to utilize simultaneous expedited approvals to accelerate global drug development.
A New Path Forward to Empower Your Team Utilizing Decentralized Clinical Trials
September 15th 2021Wednesday, September 15, 2021 at 11am EDT | 10am CDT | 4pm BST | 5pm CEST It’s with this in mind that we invite you to join us in an industry-first training and certification program that provides the specialized tools, knowledge, and skills necessary to develop and scale decentralized trials. Together, we can help codify new roles and learning paths that empower the industry to design, build, deploy and support decentralized trials. We can scale best practices and shared expertise to help trial teams break down traditional barriers, reduce cycle times, enhance data quality, and improve patient access and experience. But most importantly, in doing this we help scale a more inclusive scientific future for all.
Investigator Payments – A Critical Component in Bayer’s Sponsor of Choice Strategy
July 20th 2021Tuesday, July 20, 2021 at 11am EDT It’s not often that a sponsor calls a clinical trial solution “life-changing,” but that’s how Bayer is describing the impact of IQVIA Clinical Trial Payments as the solution rolls out to more than 20 countries. Learn how it’s possible to pay sites 2-3 times faster, eliminate end-of-study reconciliation, and reduce time spent supporting payment processes by up to 90%.